SCHEMBL30033338

SCHEMBL30033338

O=c1[nH]c2ccc(C(F)(F)F)cc2c(=O)n1-c1cncc2cccc(Br)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 2/20 0.42
▸ DDR1 Q08345 13/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ PMP22 Q01453 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KCNMA1 Q12791 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ CHUK O15111 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ KIF11 P52732 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30033508 0.89 HSP90AA1 (0.43) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30032806 0.88 DDR1 (0.43) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30032902 0.84 HSP90AA1 (0.48) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30032738 0.78 HSP90AA1 (0.43) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30033349 0.77 DDR1 (0.44) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30034350 0.76 NPEPPS (0.42) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30033014 0.75 HSP90AA1 (0.43) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30033019 0.75 DDR1 (0.52) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30033004 0.73 NPEPPS (0.49) HSP90AA1DDR1MEN1CYP1A2CYP3A4
SCHEMBL30032253 0.73 DDR1 (0.40) HSP90AA1DDR1MEN1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224223-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2022-10-27 — — WO disclosed
Send feedback